Angiodynamics announces addition of lorinda burgess to board of directors

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced the appointment of lorinda burgess to the company's board of directors. ms. burgess brings over 35 years of management, financial, and global operations experience, including over 15 years at medtronic, inc.,.
ANGO Ratings Summary
ANGO Quant Ranking